Alaunos Therapeutics, INC Form 4 insider transactions

Melinda Lackey, Legal & Administration Officer at Alaunos Therapeutics, acquired stock options on August 14, 2024.

Holger Weis, a director of Alaunos Therapeutics, acquired stock options on June 6, 2024, according to a Form 4 filing.

Jaime Vieser, a director of Alaunos Therapeutics, acquired employee stock options on June 6, 2024.

Robert W. Postma, a director of Alaunos Therapeutics, acquired 12,800 employee stock options on June 6, 2024.

Robert Hofmeister, a director at Alaunos Therapeutics, acquired 12,800 employee stock options on June 6, 2024.